Ping An Healthcare and Technology Company Limited (SEHK:1833) commences share repurchases on December 14, 2021, under the program mandated by the shareholders in the Annual General Meeting held on April 21, 2021. As per the mandate, the company is authorized to repurchase up to 114,729,420 shares, representing 10% of its issued share capital. The repurchases will lead to an enhancement of the net asset value per share and/or earnings per share for the company. The repurchases will be made out of the funds legally available for such purpose in accordance with its memorandum of association and Bye-laws and of Cayman Companies Law. The authority shall expire at the earliest of the next Annual General Meeting, the date on which the next Annual General Meeting is required to be held or the date on which the authority is varied or revoked in a General Meeting. As of April 21, 2021, the company had 1,147,294,200 shares in issue. On December 13, 2021, the company announced a share repurchase program. Under the program, the company will repurchase 56,000,000 Shares for CNY 1,380 million. The repurchases will be made from existing available cash reserves and free cash flow of the company. The repurchased shares will be cancelled. The program shall expire at the earliest of the next Annual General Meeting, the date on which the next Annual General Meeting is required to be held or the date on which the authority is varied or revoked in a General Meeting.